Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1T | 2.4T | 2.1T | 2.1T |
Cost of revenue | 1.1T | 1.2T | 1.1T | 1.1T |
Gross profit | 1.0T | 1.2T | 1.0T | 1.0T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 219.7B | 226.3B | 206.1B | 206.7B |
Other operating expenses | 74.3B | 71.1B | 69.1B | 73.4B |
Operating income | 118.9B | 362.1B | 260.1B | 163.8B |
Non operating interest income | ||||
Income | 19.0B | 17.0B | 19.6B | 26.4B |
Expense | 20.2B | 19.8B | 18.3B | 19.3B |
Other income expense | — | — | — | — |
Pretax income | 167.6B | 372.2B | 259.0B | 197.9B |
Tax provision | 29.3B | 55.3B | 52.6B | 39.8B |
Net income | 138.3B | 316.9B | 206.4B | 158.1B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 324.2B | 526.0B | 404.3B | 343.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 3.3B | 916.3M | 2.1B | 2.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |